Fibromuscular Dysplasia Treatment
Fibromuscular dysplasia cannot be cured. The goals of treatment are to improve blood flow in the affected arteries, reduce symptoms, and prevent complications (e.g., stroke). Treatment options depend on the overall health of the patient, on which arteries are affected, and on the severity of the condition.
Treatment for fibromuscular dysplasia often involves percutaneous transluminal coronary angioplasty (PTCA or angioplasty). This invasive procedure is used to reduce stenosis and improve blood flow in the coronary arteries.
PTCA usually is performed under local anesthesia and sedation. In this procedure, a contrast agent is administered to allow the physician to visualize the arteries on a monitor. The physician makes a small incision and inserts a thin, flexible tube (catheter) is into the affected artery. A tiny balloon is then passed through the catheter and is inflated to open the artery.
Patients who have fibromuscular dysplasia should not smoke. In some cases, medication (e.g., antiplatelets, anticoagulants) is recommended. In patients who develop an aneurysm, surgery may be required to prevent the blood vessel from rupturing.